6 employees
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
2019
$1.2M
from 1 investors over 1 rounds
Scope Biosciences B.V. raised $1.2M on October 29, 2021
Investors: GenDx